Candidates Suitable candidates for peptide therapy would typically like to improve their overall health and address symptoms of menopause that are affecting their quality of life
CrAT is present in mitochondria and peroxisomes 31,32 and transfers the acetyl moiety from acetyl-CoA onto carnitine to generate acetylcarnitine for organelle export via the carnitine-acylcarnitine translocase (CACT
It reduces lipid peroxidation and inflammatory agents in the body and resultant inflammatory diseases
Increasing beyond protocol ranges lacks safety data and increases risk without guaranteed benefit
Managing miscarriage Several large population cohorts and linkage studies have reported an association between endometriosis and pregnancy loss
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
